Catalyst

US2016347906A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016347906-A1
Application numberUS-201515116678-A
CountryUS
Kind codeA1
Filing dateFeb 6, 2015
Priority dateFeb 7, 2014
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides novel catalysts of formula (I), where M 1 and M 2 are different and are independently selected from Mg, Zn, Fe, Co, Al and Cr, and catalyst systems comprising these catalysts. The invention also relates to the use of the inventive catalysts and catalyst systems to catalyse the reaction between i) carbon dioxide and an epoxide, ii) an epoxide and an anhydride, or iii) a lactide and/or a lactone. The invention also relates to a method for producing a catalyst of formula (I).

First claim

Opening claim text (preview).

1 . A catalyst of formula (I): wherein: M 1 and M 2 are different and are independently selected from the group consisting of Mg, Zn, Fe, Co, Al, and Cr; each instance of R 1 and R 2 is independently hydrogen, halide, a nitro group, a nitrile group, an imine, an amine, an ether group, a silyl group, a silyl ether group, a sulfoxide group, a sulfonyl group, a sulfinate group, an acetylide group, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted haloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkoxy, optionally substituted aryloxy, optionally substituted alkylthio, optionally substituted arylthio, optionally substituted alicyclic, or optionally substituted heteroalicyclic; each instance of R 3 is independently optionally substituted alkylene, optionally substituted alkenylene, optionally substituted alkynylene, optionally substituted heteroalkylene, optionally substituted heteroalkenylene, optionally substituted heteroalkynylene, optionally substituted arylene, optionally substituted heteroarylene or optionally substituted cycloalkylene, wherein the alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene and heteroalkynylene, may optionally be interrupted by optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alicyclic, or optionally substituted heteroalicyclic; each instance of R 4 is independently H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylheteroaryl or optionally substituted alkylaryl; each instance of R 5 is independently H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylheteroaryl, or optionally substituted alkylaryl; E 1 is C and E 2 is O, S or NH, or E 1 is N and E 2 is O; each instance of X is independently OC(O)R x , OSO 2 R x , OSOR x , OSO(R x ) 2 , S(O)R x , OR x , phosphinate, halide, nitrate, hydroxyl, carbonate, amino, amido, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, or optionally substituted heteroaryl; each instance of R x is independently hydrogen, optionally substituted aliphatic, optionally substituted haloaliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted alkylaryl, or optionally substituted heteroaryl; and G is absent or independently a neutral or anionic donor ligand which is a Lewis base. 2 . The catalyst according to claim 1 , wherein M 1 and M 2 are independently selected from Mg, Zn, Fe and Co. 3 . The catalyst according to claim 1 , wherein M 1 is either Mg or Zn. 4 . The catalyst according to claim 1 , wherein M 1 is Zn and M 2 is Mg. 5 . The catalyst according to claim 1 , wherein each instance of R 2 , R 4 and R 5 is H, R 3 is an optionally substituted propylene, optionally substituted phenylene, or optionally substituted cyclohexylene, E 1 is C, and E 2 is O, S or NH. 6 . The catalyst according claim 1 , wherein each instance of R 1 is independently hydrogen, halide, amino, nitro, sulfoxide, sulfonyl, silyl, sulfinate, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkoxy, or optionally substituted alkylthio. 7 . The catalyst according to claim 1 , wherein each instance of X is independently OC(O)R x , OSO 2 R x , OS(O)R x , OSO(R x ) 2 , S(O)R x , OR x , halide, nitrate, hydroxyl, carbonate, amino, nitro, amido, optionally substituted alkyl, optionally substituted heteroalkyl, aryl, or optionally substituted heteroaryl. 8 . The catalyst according to claim 1 , wherein each instance of R x is independently optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted heteroalkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted alkylaryl. 9 . The catalyst according to claim 1 having the formula: 10 . A catalyst system comprising a catalyst of claim 1 . 11 . The catalyst system according to claim 10 , further comprising a second catalyst or a co-catalyst. 12 . The catalyst system according to claim 11 , wherein the second catalyst is a compound of formula (Ic): wherein: M 1 and M 2 may be the same or different, and are selected from the group consisting of Zn(II), Cr(II), Co(II), Mn(II), Mg(II), Fe(II), Ti(II), Cr(III)-X, Co(III)-X, Mn(III)-X, Fe(III)-X, Ca(II), Ge(II), Al(III)-X, Ti(III)-X, V(III)-X, Ge(IV)-(X) 2 and Ti(IV)-(X) 2 ; each instance of R 1 and R 2 is independently hydrogen, halide, a nitro group, a nitrile group, an imine, an amine, an ether group, a silyl group, a silyl ether group, a sulfoxide group, a sulfonyl group, a sulfinate group, an acetylide group, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted haloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkoxy, optionally substituted aryloxy, optionally substituted alkylthio, optionally substituted arylthio, optionally substituted alicyclic, or optionally substituted heteroalicyclic; each instance of R 3 is independently optionally substituted alkylene, optionally substituted alkenylene, optionally substituted alkynylene, optionally substituted heteroalkylene, optionally substituted heteroalkenylene, optionally substituted heteroalkynylene, optionally substituted arylene, optionally substituted heteroarylene or optionally substituted cycloalkylene, wherein the alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene and heteroalkynylene, may optionally be interrupted by optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alicyclic, or optionally substituted heteroalicyclic; each instance of R 4 is independently H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylheteroaryl or optionally substituted alkylaryl; each instance of R 5 is independently H, optionally substituted aliphatic, optionally substituted heteroaliphatic, optionally substituted alicyclic, optionally substituted heteroalicyclic, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylheteroaryl, or optionally substituted alkylaryl; E 1 is C and E 2 is O, S or NH, or E 1 is N and E 2 is O; each instance of X is independently OC(O)R x , OSO 2 R x , OSOR x , OSO(R x ) 2 , S(O)R x , OR x , phosphinate, halide, n

Assignees

Inventors

Classifications

  • Magnesium · CPC title

  • Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution · CPC title

  • Zinc · CPC title

  • without a metal-carbon linkage · CPC title

  • At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016347906A1 cover?
The present invention provides novel catalysts of formula (I), where M 1 and M 2 are different and are independently selected from Mg, Zn, Fe, Co, Al and Cr, and catalyst systems comprising these catalysts. The invention also relates to the use of the inventive catalysts and catalyst systems to catalyse the reaction between i) carbon dioxide and an epoxide, ii) an epoxide and an anhydride, or…
Who is the assignee on this patent?
Imp Innovations Ltd
What technology area does this patent fall under?
Primary CPC classification B01J31/2243. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).